Company Profile for Metabasis Therapeutics, Inc.Metabasis metabasis /me·tab·a·sis/ (me-tab´ah-sis) a change in the manifestations or course of a disease. me·tab·a·sis n. A change in the symptoms, course, or treatment of a disease. is a biopharmaceutical company using its proprietary technologies, scientific expertise and unique capabilities for targeting the liver and liver pathways. The Company has established a broad pipeline of product candidates and advanced research programs targeting large markets with significant unmet un·met adj. Not satisfied or fulfilled: unmet demands. needs. Metabasis' core area of focus is on the discovery and development of drug candidates to treat metabolic diseases metabolic disease, n a disorder that causes dysfunction of the metabolic action of the body, resulting in loss of control of homeostasis. paraneoplastic syndrome such as hyperlipidemia hyperlipidemia /hy·per·lip·id·emia/ (-lip?i-de´me-ah) elevated concentrations of any or all of the lipids in the plasma, including hypertriglyceridemia, hypercholesterolemia, etc. and diabetes, among others. Although not a core focus of the Company, Metabasis has also discovered and developed drug candidates indicated for the treatment of liver diseases Liver Disease Definition Liver disease is a general term for any damage that reduces the functioning of the liver. Description The liver is a large, solid organ located in the upper right-hand side of the abdomen. such as hepatitis hepatitis (hĕp'ətī`tĭs), inflammation of the liver. There are many types of hepatitis. Causes include viruses, toxic chemicals, alcohol consumption, parasites and bacteria, and certain drugs. and primary liver cancer Liver Cancer Definition Liver cancer is a relatively rare form of cancer but has a high mortality rate. Liver cancers can be classified into two types. , which it now intends to license or partner. All product candidates were developed internally using proprietary technologies. < < Company: Metabasis Therapeutics, Inc. < < < < Headquarters Address: 11119 North Torrey Pines Road < < La Jolla, CA 92037 < < < < Main Telephone: 858-587-2770 < < < < Website: www.mbasis.com < < < < Ticker/ISIN: MBRX (NASDAQ)/US59101M1053 < < < < Type of Organization: Public < < < < Industry: Biotechnology < < < < Key Executives: President & CEO: Dr. Paul Laikind < < < < Investor Relations < < Contact: Constance Bienfait < < Phone: 858-622-5575 < < Email: bienfait@mbasis.com |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion